WTA

Washington Trust Advisors Portfolio holdings

AUM $1.23B
1-Year Return 20.59%
This Quarter Return
-3.13%
1 Year Return
+20.59%
3 Year Return
+82.81%
5 Year Return
10 Year Return
AUM
$1.41B
AUM Growth
-$68.7M
Cap. Flow
+$3.33M
Cap. Flow %
0.24%
Top 10 Hldgs %
31.65%
Holding
1,044
New
41
Increased
180
Reduced
360
Closed
47

Sector Composition

1 Technology 15.13%
2 Healthcare 13.99%
3 Industrials 10.75%
4 Communication Services 9.78%
5 Consumer Discretionary 9.29%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
KURA icon
951
Kura Oncology
KURA
$706M
$2K ﹤0.01%
115
LUNG icon
952
Pulmonx
LUNG
$70.9M
$2K ﹤0.01%
95
LYB icon
953
LyondellBasell Industries
LYB
$17.5B
$2K ﹤0.01%
15
NCLH icon
954
Norwegian Cruise Line
NCLH
$11.6B
$2K ﹤0.01%
100
NEOG icon
955
Neogen
NEOG
$1.25B
$2K ﹤0.01%
76
NEO icon
956
NeoGenomics
NEO
$1.04B
$2K ﹤0.01%
204
NTLA icon
957
Intellia Therapeutics
NTLA
$1.25B
$2K ﹤0.01%
29
POST icon
958
Post Holdings
POST
$5.86B
$2K ﹤0.01%
34
-18
-35% -$1.06K
REG icon
959
Regency Centers
REG
$13.4B
$2K ﹤0.01%
33
RENT
960
Rent the Runway
RENT
$24.5M
$2K ﹤0.01%
15
TWST icon
961
Twist Bioscience
TWST
$1.55B
$2K ﹤0.01%
32
UP icon
962
Wheels Up
UP
$1.73B
$2K ﹤0.01%
52
VTR icon
963
Ventas
VTR
$30.8B
$2K ﹤0.01%
33
XLE icon
964
Energy Select Sector SPDR Fund
XLE
$27.2B
$2K ﹤0.01%
32
XLP icon
965
Consumers Staples Select Sector SPDR Fund
XLP
$15.8B
$2K ﹤0.01%
32
GAP
966
The Gap, Inc.
GAP
$8.88B
$2K ﹤0.01%
163
-1,274
-89% -$15.6K
KRTX
967
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$2K ﹤0.01%
+19
New +$2K
RETA
968
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$2K ﹤0.01%
58
XM
969
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
$2K ﹤0.01%
54
PRTY
970
DELISTED
Party City Holdco Inc.
PRTY
$2K ﹤0.01%
+420
New +$2K
DRE
971
DELISTED
Duke Realty Corp.
DRE
$2K ﹤0.01%
30
CFRX
972
DELISTED
ContraFect Corporation
CFRX
$2K ﹤0.01%
5
AAL icon
973
American Airlines Group
AAL
$8.49B
$1K ﹤0.01%
50
STRO icon
974
Sutro Biopharma
STRO
$86.5M
$1K ﹤0.01%
179
TAK icon
975
Takeda Pharmaceutical
TAK
$48.3B
$1K ﹤0.01%
35